Signal
FDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD, Truqap
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-03-06 16:27 UTCUpdated 2026-03-06 17:20 UTC
redditrss
truqap_fierce_pharma
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
The FDA is ending a roughly nine-month hiatus of drug-related advisory committee meetings, convening its first session of 2026 to scrutinize a pair of oncology applications from AstraZeneca.
Score total
1.38
Momentum 24h
3
Posts
3
Origins
2
Source types
2
Duplicate ratio
0%
All evidence
All evidence
FDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD, Truqap
biotech · fiercebiotech.com · 2026-03-06 17:20 UTC
The FDA is ending a roughly eight-month hiatus of drug-related advisory committee meetings, convening its first session of 2026 to scrutinize a pair of oncology applications fro...
Fierce Pharma (All) · fiercepharma.com · 2026-03-06 16:27 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- biotech (1)
- Fierce Pharma (All) (1)
Top origin domains (this list)
- fiercebiotech.com (1)
- fiercepharma.com (1)